Illustration, AI-generated from the story text. Tap a panel to read the story through it.

Shanghai's NeuroXess raised 700 million yuan (about $98 million) in a co-led by SDIC Juli, Shenzhen Capital Group and Qinzhi Capital, TechNode reported on October 28th.

The money goes to clinical trials, regulatory work and manufacturing, and the company says it wants its on the medical market at scale within two years.

It already runs a 14,300-square-meter factory in Jiangxi. Chinese implant makers are moving to production while US rivals are still in trials, backed by state-linked investors who treat neurotechnology as strategic.
NeuroXess raises 700 million yuan to take its brain implants to market
Shanghai's NeuroXess raised 700 million yuan (about $98 million) in a Series B co-led by SDIC Juli, Shenzhen Capital Group and Qinzhi Capital, TechNode reported on October 28th. The money goes to clinical trials, regulatory work and manufacturing, and the company says it wants its brain-computer interface on the medical market at scale within two years. It already runs a 14,300-square-meter factory in Jiangxi.
Chinese implant makers are moving to production while US rivals are still in trials, backed by state-linked investors who treat neurotechnology as strategic. SourcesB
Sources
This story ran in the Morning Brief of November 1st 2026.